Boadie W. Dunlop and Charles B. Nemeroff
- Published in print:
- 2009
- Published Online:
- February 2010
- ISBN:
- 9780195373035
- eISBN:
- 9780199865543
- Item type:
- chapter
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/acprof:oso/9780195373035.003.0040
- Subject:
- Neuroscience, Molecular and Cellular Systems, History of Neuroscience
Many of the studies exploring dopamine (DA) function in depression have produced inconsistent findings. Contributors to this inconsistency include the diagnostic heterogeneity of major depressive ...
More
Many of the studies exploring dopamine (DA) function in depression have produced inconsistent findings. Contributors to this inconsistency include the diagnostic heterogeneity of major depressive disorder (MDD); failure to control for age, bipolar disorder, and comorbid diagnoses; and variation in patient medication treatment status at the time of the study. Despite this variability, there is now a convergence of data from animal models, genetics, neuroimaging, and human clinical trials that strengthens the case for DA dysfunction in the pathophysiology of major depression, at least in a significant subgroup of patients. This chapter comprehensively reviews the current evidence, with subsequent recommendations for future studies of dopaminergic signaling in depression and its treatment.Less
Many of the studies exploring dopamine (DA) function in depression have produced inconsistent findings. Contributors to this inconsistency include the diagnostic heterogeneity of major depressive disorder (MDD); failure to control for age, bipolar disorder, and comorbid diagnoses; and variation in patient medication treatment status at the time of the study. Despite this variability, there is now a convergence of data from animal models, genetics, neuroimaging, and human clinical trials that strengthens the case for DA dysfunction in the pathophysiology of major depression, at least in a significant subgroup of patients. This chapter comprehensively reviews the current evidence, with subsequent recommendations for future studies of dopaminergic signaling in depression and its treatment.
Jacqueline Corcoran
- Published in print:
- 2010
- Published Online:
- September 2010
- ISBN:
- 9780195375718
- eISBN:
- 9780199865529
- Item type:
- chapter
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/acprof:oso/9780195375718.003.0007
- Subject:
- Social Work, Children and Families, Health and Mental Health
The prevalence of diagnosable depressive disorders in children is 2.8% and in adolescents is 5.7%. This chapter reviews the evidence basis for the treatment of depressive disorders in youth. ...
More
The prevalence of diagnosable depressive disorders in children is 2.8% and in adolescents is 5.7%. This chapter reviews the evidence basis for the treatment of depressive disorders in youth. Cognitive-behavioral therapy has predominated in the research literature, with interpersonal therapy also receiving empirical support. In general, however, effects of intervention are small. Medication studies indicate that while antidepressants improve depression symptoms, they also increase suicidality in youth. Fluoxetine is the only SSRI with significant benefit for children, and sertaline and fluoxetine have significant benefits for adolescents. Large-scale studies on the differential efficacy of combining psychotherapy versus offering single treatments conflict in their findings. Interventions are evaluated against how well they address risk factors for the development of depression and adjustment for afflicted youth, and recommendations are advanced.Less
The prevalence of diagnosable depressive disorders in children is 2.8% and in adolescents is 5.7%. This chapter reviews the evidence basis for the treatment of depressive disorders in youth. Cognitive-behavioral therapy has predominated in the research literature, with interpersonal therapy also receiving empirical support. In general, however, effects of intervention are small. Medication studies indicate that while antidepressants improve depression symptoms, they also increase suicidality in youth. Fluoxetine is the only SSRI with significant benefit for children, and sertaline and fluoxetine have significant benefits for adolescents. Large-scale studies on the differential efficacy of combining psychotherapy versus offering single treatments conflict in their findings. Interventions are evaluated against how well they address risk factors for the development of depression and adjustment for afflicted youth, and recommendations are advanced.
Barbara J. Burns, Scott N. Compton, Helen L. Egger, Elizabeth M. Z. Farmer, and Elizabeth B. Robertson
- Published in print:
- 2002
- Published Online:
- January 2009
- ISBN:
- 9780195134575
- eISBN:
- 9780199864065
- Item type:
- chapter
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/acprof:oso/9780195134575.003.0011
- Subject:
- Social Work, Health and Mental Health, Communities and Organizations
This chapter presents the evidence base for clinic and school-based interventions for four common childhood disorders or related symptom patterns: attention-deficit/hyperactivity disorder (ADHD), ...
More
This chapter presents the evidence base for clinic and school-based interventions for four common childhood disorders or related symptom patterns: attention-deficit/hyperactivity disorder (ADHD), major depressive disorder (MDD), disruptive behavior disorders, and anxiety disorders and related symptoms. It shows that within the existing base for each disorder, psychosocial interventions include an array of behavioral approaches. The psychopharmacology evidence base is strongest for ADHD, weaker for other disorders, and virtually nonexistent for anxiety disorders. Adjunctive studies examining a combination of psychosocial and psychopharmacological interventions were rare, with the largest and most sophisticated one for ADHD.Less
This chapter presents the evidence base for clinic and school-based interventions for four common childhood disorders or related symptom patterns: attention-deficit/hyperactivity disorder (ADHD), major depressive disorder (MDD), disruptive behavior disorders, and anxiety disorders and related symptoms. It shows that within the existing base for each disorder, psychosocial interventions include an array of behavioral approaches. The psychopharmacology evidence base is strongest for ADHD, weaker for other disorders, and virtually nonexistent for anxiety disorders. Adjunctive studies examining a combination of psychosocial and psychopharmacological interventions were rare, with the largest and most sophisticated one for ADHD.
Ellen M. Migo, Steve C.R. Williams, William R. Crum, Matthew J. Kempton, and Ulrich Ettinger
- Published in print:
- 2010
- Published Online:
- January 2011
- ISBN:
- 9780195393804
- eISBN:
- 9780199863495
- Item type:
- chapter
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/acprof:oso/9780195393804.003.0008
- Subject:
- Neuroscience, Disorders of the Nervous System
There is a clear need for biomarkers in neuro-degenerative and psychiatric disorders for both early and differential diagnosis, personalized prediction of treatment response, and in drug discovery. ...
More
There is a clear need for biomarkers in neuro-degenerative and psychiatric disorders for both early and differential diagnosis, personalized prediction of treatment response, and in drug discovery. Non-invasive neuroimaging is a key area for biomarker development because it connects behavioural outcomes with structural, functional, and molecular mechanisms. This chapter discusses neuroimaging biomarkers in relation to dementia, schizophrenia, and mood disorders (bipolar and major depressive disorders). The current candidate biomarkers for each disorder are reviewed, across the full range of imaging modalities, followed by an evaluation of their future prospects. The chapter concludes that there has been substantial progress towards personalized neuroimaging-based biomarkers but much remains to be done. Such biomarkers must be validated for specific disorders and may include neuroimaging and non-neuroimaging components.Less
There is a clear need for biomarkers in neuro-degenerative and psychiatric disorders for both early and differential diagnosis, personalized prediction of treatment response, and in drug discovery. Non-invasive neuroimaging is a key area for biomarker development because it connects behavioural outcomes with structural, functional, and molecular mechanisms. This chapter discusses neuroimaging biomarkers in relation to dementia, schizophrenia, and mood disorders (bipolar and major depressive disorders). The current candidate biomarkers for each disorder are reviewed, across the full range of imaging modalities, followed by an evaluation of their future prospects. The chapter concludes that there has been substantial progress towards personalized neuroimaging-based biomarkers but much remains to be done. Such biomarkers must be validated for specific disorders and may include neuroimaging and non-neuroimaging components.
Barbara J. Sahakian and Sharon Morein-Zamir
- Published in print:
- 2011
- Published Online:
- May 2011
- ISBN:
- 9780199600434
- eISBN:
- 9780191725623
- Item type:
- chapter
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/acprof:oso/9780199600434.003.0023
- Subject:
- Psychology, Cognitive Psychology, Developmental Psychology
The symptoms of depression include persistent low mood, feelings of helplessness, hopelessness, or worthlessness, and anhedonia, or the inability to experience pleasure. Mood is influenced by a ...
More
The symptoms of depression include persistent low mood, feelings of helplessness, hopelessness, or worthlessness, and anhedonia, or the inability to experience pleasure. Mood is influenced by a complex interaction of genetic, social, environmental, and other factors, such as substance abuse. Depression is further characterized by dysfunctional attitudes and negative automatic thoughts or ruminations. Psychiatric diagnostic criteria distinguish patients who experience only depressive episodes (unipolar depression or major depressive disorder, MDD) from patients who experience depressive episodes but also manic ones (bipolar disorder, BD). The symptoms of mania, on the other hand, include euphoria, over-activity, distractibility, socially inappropriate behaviour, increased appetite, and impaired insight. Thus, the emotional states of patients with depression and mania can be considered to represent two polar extremes on a mood spectrum. The states manifested in depression and mania are pathological in that they are extreme, disrupt quality of life, and are persistent and often recurrent. This chapter examines not only depression in MDD, but contrasts it with the, at times similar but at times diametrically opposed, symptoms of other disorders, such as BD, to achieve better insight. It also examines resilience in healthy individuals, i.e., how can mood remain normal despite factors such as adverse life events. Research on resilience has focused on determining the protective factors that allow some individuals to have more positive outcomes, despite being exposed to a variety of stressors.Less
The symptoms of depression include persistent low mood, feelings of helplessness, hopelessness, or worthlessness, and anhedonia, or the inability to experience pleasure. Mood is influenced by a complex interaction of genetic, social, environmental, and other factors, such as substance abuse. Depression is further characterized by dysfunctional attitudes and negative automatic thoughts or ruminations. Psychiatric diagnostic criteria distinguish patients who experience only depressive episodes (unipolar depression or major depressive disorder, MDD) from patients who experience depressive episodes but also manic ones (bipolar disorder, BD). The symptoms of mania, on the other hand, include euphoria, over-activity, distractibility, socially inappropriate behaviour, increased appetite, and impaired insight. Thus, the emotional states of patients with depression and mania can be considered to represent two polar extremes on a mood spectrum. The states manifested in depression and mania are pathological in that they are extreme, disrupt quality of life, and are persistent and often recurrent. This chapter examines not only depression in MDD, but contrasts it with the, at times similar but at times diametrically opposed, symptoms of other disorders, such as BD, to achieve better insight. It also examines resilience in healthy individuals, i.e., how can mood remain normal despite factors such as adverse life events. Research on resilience has focused on determining the protective factors that allow some individuals to have more positive outcomes, despite being exposed to a variety of stressors.
Harold Kincaid
- Published in print:
- 2017
- Published Online:
- September 2017
- ISBN:
- 9780262035484
- eISBN:
- 9780262341752
- Item type:
- chapter
- Publisher:
- The MIT Press
- DOI:
- 10.7551/mitpress/9780262035484.003.0012
- Subject:
- Psychology, Clinical Psychology
Scientific commonsense would suggest that very young children cannot have psychiatric disorders such as bipolar disorder or major depression since they do not have the level of development to express ...
More
Scientific commonsense would suggest that very young children cannot have psychiatric disorders such as bipolar disorder or major depression since they do not have the level of development to express the complex characteristics of these disorders. This chapter provides a detailed survey of current evidence supporting this common sense claim. The chapter first gives a general perspective on DSM that will be applied in looking at childhood psychiatric diagnoses and should be of some interest in its own right. I argue that there are some DSM based categorizations--those of major depressive disorder and bipolar disorder--that have substantial empirical support. I look at these two classifications as the best case for pediatric psychiatric disorders. I argue that this best case fails given our current state of knowledge, raising doubts in general about psychiatric diagnoses in small children. This conclusion has practical importance, since small children are increasingly being given powerful psychoactive drugs.Less
Scientific commonsense would suggest that very young children cannot have psychiatric disorders such as bipolar disorder or major depression since they do not have the level of development to express the complex characteristics of these disorders. This chapter provides a detailed survey of current evidence supporting this common sense claim. The chapter first gives a general perspective on DSM that will be applied in looking at childhood psychiatric diagnoses and should be of some interest in its own right. I argue that there are some DSM based categorizations--those of major depressive disorder and bipolar disorder--that have substantial empirical support. I look at these two classifications as the best case for pediatric psychiatric disorders. I argue that this best case fails given our current state of knowledge, raising doubts in general about psychiatric diagnoses in small children. This conclusion has practical importance, since small children are increasingly being given powerful psychoactive drugs.
Revathy U. Chottekalapanda, Paul Greengard, and Yotam Sagi
- Published in print:
- 2019
- Published Online:
- January 2019
- ISBN:
- 9780190455132
- eISBN:
- 9780190455156
- Item type:
- chapter
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/oso/9780190455132.003.0004
- Subject:
- Psychology, Cognitive Psychology, Cognitive Neuroscience
Major depressive disorder (MDD) affects more than 20 million people in the United States. Depression is comorbid with other psychiatric disorders and can increase risks of drug and alcohol abuse and ...
More
Major depressive disorder (MDD) affects more than 20 million people in the United States. Depression is comorbid with other psychiatric disorders and can increase risks of drug and alcohol abuse and suicide. Available antidepressants have limited efficacy and new therapeutic targets are needed. MDD and antidepressant responses are mediated via neurotransmitter signaling mechanisms and inflammatory responses involving an integrated network of limbic brain regions that include hippocampus, prefrontal cortex, and nucleus accumbens. Although this limbic circuit is broadly described, researchers do not understand how the properties of neurons within the circuit are altered in depression. The authors present the regulation of the p11 signaling module in this circuit, describe the diagnostic aspects of p11 function, and lay out a cellular and molecular framework for the understanding of MDD and the development of novel antidepressant therapies.Less
Major depressive disorder (MDD) affects more than 20 million people in the United States. Depression is comorbid with other psychiatric disorders and can increase risks of drug and alcohol abuse and suicide. Available antidepressants have limited efficacy and new therapeutic targets are needed. MDD and antidepressant responses are mediated via neurotransmitter signaling mechanisms and inflammatory responses involving an integrated network of limbic brain regions that include hippocampus, prefrontal cortex, and nucleus accumbens. Although this limbic circuit is broadly described, researchers do not understand how the properties of neurons within the circuit are altered in depression. The authors present the regulation of the p11 signaling module in this circuit, describe the diagnostic aspects of p11 function, and lay out a cellular and molecular framework for the understanding of MDD and the development of novel antidepressant therapies.
Justin M. Simpson and Glendon L. Moriarty
- Published in print:
- 2013
- Published Online:
- November 2015
- ISBN:
- 9780231158831
- eISBN:
- 9780231536097
- Item type:
- chapter
- Publisher:
- Columbia University Press
- DOI:
- 10.7312/columbia/9780231158831.003.0003
- Subject:
- Psychology, Clinical Psychology
This chapter reviews the literature on treatment programs for people with severe mental illness (SMI), which includes schizophrenia and schizoaffective disorder, bipolar and major depressive ...
More
This chapter reviews the literature on treatment programs for people with severe mental illness (SMI), which includes schizophrenia and schizoaffective disorder, bipolar and major depressive disorder, posttraumatic stress disorder and panic disorder, and substance-related disorders. Several modalities of empirically supported treatments are covered to highlight the need for a multimodal approach to treating SMI. Emphasis is placed on the evidence related to brief, crisis, or acute phase treatment. The chapter also provides examples of therapeutic strategies used to address common symptoms of various severe mental illnesses. Most treatments are born out of a cognitive-behavioral or social learning theoretical framework. In conclusion, the severe mental illness treatment literature lends support to the popular notion that psychiatric problems are determined by multiple factors and therefore require multifaceted psychotherapy plans.Less
This chapter reviews the literature on treatment programs for people with severe mental illness (SMI), which includes schizophrenia and schizoaffective disorder, bipolar and major depressive disorder, posttraumatic stress disorder and panic disorder, and substance-related disorders. Several modalities of empirically supported treatments are covered to highlight the need for a multimodal approach to treating SMI. Emphasis is placed on the evidence related to brief, crisis, or acute phase treatment. The chapter also provides examples of therapeutic strategies used to address common symptoms of various severe mental illnesses. Most treatments are born out of a cognitive-behavioral or social learning theoretical framework. In conclusion, the severe mental illness treatment literature lends support to the popular notion that psychiatric problems are determined by multiple factors and therefore require multifaceted psychotherapy plans.
Justin Simpson and Glendon Moriarty
- Published in print:
- 2013
- Published Online:
- November 2015
- ISBN:
- 9780231158831
- eISBN:
- 9780231536097
- Item type:
- book
- Publisher:
- Columbia University Press
- DOI:
- 10.7312/columbia/9780231158831.001.0001
- Subject:
- Psychology, Clinical Psychology
The multimodal treatment of acute psychiatric illness involves a set of integrated, systematic interventions that stabilize individuals with severe mental illness and help them avoid unnecessary ...
More
The multimodal treatment of acute psychiatric illness involves a set of integrated, systematic interventions that stabilize individuals with severe mental illness and help them avoid unnecessary psychiatric hospitalization. This volume focuses on those suffering from schizophrenia, schizoaffective disorder, bipolar disorder, major depressive disorder, severe anxiety, and substance dependence, and provides individual practitioners and professional teams with the tools for responding to crisis and delivering acute care. The text includes real-world case examples, diagrams, and printable worksheets.Less
The multimodal treatment of acute psychiatric illness involves a set of integrated, systematic interventions that stabilize individuals with severe mental illness and help them avoid unnecessary psychiatric hospitalization. This volume focuses on those suffering from schizophrenia, schizoaffective disorder, bipolar disorder, major depressive disorder, severe anxiety, and substance dependence, and provides individual practitioners and professional teams with the tools for responding to crisis and delivering acute care. The text includes real-world case examples, diagrams, and printable worksheets.
Larry E. Beutler, John F. Clarkin, and Bruce Bongar
- Published in print:
- 2000
- Published Online:
- March 2012
- ISBN:
- 9780195105308
- eISBN:
- 9780199848522
- Item type:
- chapter
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/acprof:oso/9780195105308.003.0006
- Subject:
- Psychology, Clinical Psychology
This chapter defines basic treatment guidelines through a cross-validation of the tentative suggestions provided earlier. The cross-validation ...
More
This chapter defines basic treatment guidelines through a cross-validation of the tentative suggestions provided earlier. The cross-validation relies on the mixed sample comprising the four samples described in this book. Two of the data sets consist of individuals who had been carefully and reliably diagnosed with major depressive disorders. Patients in these samples were treated with either group or individual cognitive therapy, group experiential therapy, individual psychodynamic therapy, antidepressant therapy, or a self-directed bibliotherapy. The chapter included two other samples in which depression was more broadly distributed. These samples included a general outpatient clinic sample on which was practiced the usual form of general outpatient care and a sample of patients being treated for alcohol abuse in a controlled clinical trial of cognitive therapy and family systems therapy.Less
This chapter defines basic treatment guidelines through a cross-validation of the tentative suggestions provided earlier. The cross-validation relies on the mixed sample comprising the four samples described in this book. Two of the data sets consist of individuals who had been carefully and reliably diagnosed with major depressive disorders. Patients in these samples were treated with either group or individual cognitive therapy, group experiential therapy, individual psychodynamic therapy, antidepressant therapy, or a self-directed bibliotherapy. The chapter included two other samples in which depression was more broadly distributed. These samples included a general outpatient clinic sample on which was practiced the usual form of general outpatient care and a sample of patients being treated for alcohol abuse in a controlled clinical trial of cognitive therapy and family systems therapy.
Candi K. Cann
- Published in print:
- 2014
- Published Online:
- September 2014
- ISBN:
- 9780813145419
- eISBN:
- 9780813145495
- Item type:
- chapter
- Publisher:
- University Press of Kentucky
- DOI:
- 10.5810/kentucky/9780813145419.003.0001
- Subject:
- Society and Culture, Cultural Studies
The denial of death in contemporary American society can be found in bereavement policies, the reclassification of grief as a major depressive disorder, and the emerging popularity of grassroots ...
More
The denial of death in contemporary American society can be found in bereavement policies, the reclassification of grief as a major depressive disorder, and the emerging popularity of grassroots memorialization. This chapter briefly traces the changing understanding of grief and examines newly emerging bereavement practices in light of these changes.Less
The denial of death in contemporary American society can be found in bereavement policies, the reclassification of grief as a major depressive disorder, and the emerging popularity of grassroots memorialization. This chapter briefly traces the changing understanding of grief and examines newly emerging bereavement practices in light of these changes.
